ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101. A total of 88 filers reported holding ADURO BIOTECH INC in Q3 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $193,000 | +484.8% | 79,095 | +455.7% | 0.00% | +100.0% |
| Q2 2020 | $33,000 | +450.0% | 14,234 | +168.4% | 0.00% | – |
| Q4 2019 | $6,000 | -14.3% | 5,304 | +19.5% | 0.00% | – |
| Q2 2019 | $7,000 | -78.1% | 4,439 | -45.6% | 0.00% | -100.0% |
| Q1 2019 | $32,000 | -62.4% | 8,161 | -74.5% | 0.00% | -66.7% |
| Q4 2018 | $85,000 | +962.5% | 31,972 | +2680.2% | 0.01% | +500.0% |
| Q3 2018 | $8,000 | -81.8% | 1,150 | -81.6% | 0.00% | -50.0% |
| Q2 2018 | $44,000 | – | 6,258 | +22250.0% | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 28 | -96.9% | 0.00% | -100.0% |
| Q2 2017 | $10,000 | +900.0% | 900 | +800.0% | 0.00% | – |
| Q1 2017 | $1,000 | -88.9% | 100 | -86.9% | 0.00% | -100.0% |
| Q4 2016 | $9,000 | +350.0% | 763 | +371.0% | 0.00% | – |
| Q1 2016 | $2,000 | 0.0% | 162 | +88.4% | 0.00% | – |
| Q4 2015 | $2,000 | -60.0% | 86 | -42.7% | 0.00% | – |
| Q2 2015 | $5,000 | – | 150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 5,118,560 | $12,438,000 | 0.72% |
| Rubric Capital Management LP | 1,629,321 | $3,959,000 | 0.37% |
| Burrage Capital Management LLC | 135,898 | $330,000 | 0.26% |
| Artal Group S.A. | 902,500 | $2,193,000 | 0.05% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,141,278 | $2,773,000 | 0.05% |
| Point72 Asset Management, L.P. | 2,050,000 | $4,982,000 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 567,181 | $1,378,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 34,241 | $83,000 | 0.01% |
| Renaissance Technologies | 4,384,010 | $10,653,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 802,749 | $1,951,000 | 0.01% |